Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
2.590
+0.050 (1.97%)
At close: Apr 2, 2026, 4:00 PM EDT
2.585
-0.005 (-0.19%)
After-hours: Apr 2, 2026, 6:58 PM EDT
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $921.82 million as of April 2, 2026. Its market cap has decreased by -24.04% in one year.
Market Cap
921.82M
Enterprise Value
1.21B
1-Year Change
-24.04%
Ranking
Category
Stock Price
$2.59
Market Cap Chart
Since the IPO on November 2, 2010, Evotec SE's market cap has increased from $366.30M to $921.82M, an increase of 151.66%. That is a compound annual growth rate of 6.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 921.82M | -18.91% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | 38.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harrow | 1.31B |
| Alvotech | 1.14B |
| Collegium Pharmaceutical | 1.03B |
| Cronos Group | 958.86M |
| Amphastar Pharmaceuticals | 927.82M |
| Pacira BioSciences | 919.12M |
| BioAge Labs | 776.65M |
| Tilray Brands | 763.12M |